Skip to main content
SpringerLink
Log in

Treating Alzheimer’s? Don’t forget about cholinesterase inhibitor drug interactions

  • Drug Reaction and Interaction
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Bentué-Ferrer D, Tribut O, Polard E, et al. Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists. CNS Drugs 2003; 17(13): 947–63

    Article  PubMed  Google Scholar 

  2. Allain H, Bentué-Ferrer D, Tribut O, et al. Drugs and vascular dementia. Dement Geriatr Cogn Disord 2003; 16: 1–6

    Article  PubMed  CAS  Google Scholar 

  3. Weinstock M. Selectivity of cholinesterase inhibition: clinical implications for the treatment of Alzheimer’ s disease. CNS Drugs 1999; 12: 307–23

    Article  CAS  Google Scholar 

  4. VanDenBerg CM, Kazmi Y, Jann MW. Cholinesterase inhibitors for the treatment of Alzheimer’s disease in the elderly. Drugs Aging 2000; 16: 123–38

    Article  PubMed  CAS  Google Scholar 

  5. Nordberg A, Svensson AL. Cholinesterase inhibitors in the treatment of Alzheimer’s disease: a comparison of tolerability and pharmacology. Drug Saf 1998; 19: 465–80

    Article  PubMed  CAS  Google Scholar 

  6. Schachter AS, Davis KL. Guidelines for the appropriate use of cholinesterase inhibitors in patients with Alzheimer’s disease. CNS Drugs 1999; 11: 281–8

    Article  Google Scholar 

  7. Arai M. Parkinsonism onset in a patient concurrently using tiapride and donepezil. Intern Med 2000; 39: 863

    Article  PubMed  CAS  Google Scholar 

  8. Magnuson TM, Keller BK, Burke WJ. Extrapyramidal side effects in a patient treated with risperidone plus donepezil. Am J Psychiatry 1998; 155: 1458–9

    PubMed  CAS  Google Scholar 

  9. Janssen. Reminyl tablets: prescribing information. Turnhoutseweg: Janssen Pharmaceutica NV, 2000 Jul 11

  10. Becquemont L, Ragueneau I, Le Bot MA, et al. Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans. Clin Pharmacol Ther 1997; 61: 619–27

    Article  PubMed  CAS  Google Scholar 

  11. Larsen JT, Hansen LL, Spigset O, et al. Fluvoxamine is a potent inhibitor of tacrine metabolism in vivo. Eur J Clin Pharmacol 1999; 55: 375–82

    Article  PubMed  CAS  Google Scholar 

  12. Forgue ST, Reece PA, Sedman AJ, et al. Inhibition of tacrine oral clearance by cimetidine. Clin Pharmacol Ther 1996; 59: 444–9

    Article  PubMed  CAS  Google Scholar 

  13. Laine K, Palovaara S, Tapanainen P, et al. Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy. Clin Pharmacol Ther 1999; 66: 602–8

    PubMed  CAS  Google Scholar 

  14. Welty D, Pool W, Woolf T, et al. The effect of smoking on the pharmacokinetics and metabolism of Cognex in healthy volunteers [abstract]. Pharm Res 1993; 10 Suppl. 10: S334

    Google Scholar 

  15. Zevin S, Benowitz NL. Drug interactions with tobacco smoking: an update. Clin Pharmacokinet 1999; 36: 425–38

    Article  PubMed  CAS  Google Scholar 

  16. Parke-Davis. Cognex (tacrine hydrochloride): prescribing information. Morris Plains (NJ): Parke-Davis, 1993

  17. McSwain ML, Forman LM. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol [letter]. J Clin Psychopharmacol 1995; 15: 284

    Article  PubMed  CAS  Google Scholar 

  18. Maany I. Adverse interaction of tacrine and haloperidol [letter]. Am J Psychiatry 1996; 153: 1504

    PubMed  CAS  Google Scholar 

  19. Defilippi JL, Crismon ML. Drug interactions with cholinesterase inhibitors. Drugs Aging 2003; 20(6): 437–44

    Article  PubMed  CAS  Google Scholar 

  20. Grossberg GT, Stahelin HB, Messina JC. Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications. Int J Geriat Psychiatry 2000; 15: 242–7

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treating Alzheimer’s? Don’t forget about cholinesterase inhibitor drug interactions. Drugs Ther. Perspect 20, 20–22 (2004). https://doi.org/10.2165/00042310-200420070-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200420070-00007

Search

Navigation